|
|
Article: Meta-analysis of 7 studies gives edge to Cypher stent.
- Article from:
- Medical Device Daily
- Article date:
- October 21, 2005
CopyrightCOPYRIGHT 2005 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Transcatheter Cardiovascular Therapeutics 2005
Meta-analysis of 7 studies gives edge to Cypher stent
By AARON LORENZO
Medical Device Daily Washington Editor
A head-to-head comparison showed that the Cypher sirolimus-eluting stent from Cordis (Miami Lakes, Florida) outperforms Taxus in target lesion revascularization and restenosis rates. Specifically, the Cypher stent reduced the need for retreatment by about 30% compared to Boston Scientific?s (Natick, Massachusetts) paclitaxel-eluting Taxus stent.
Those conclusions were drawn by a meta-analysis of the two drug-eluting stents in seven studies that include a total of 4,214 ...